The 9 TEAEs leading to ivonescimab discontinuation included elevated alanine aminotransferase, elevated serum creatinine, musculoskeletal pain, hypothyroidism, rash, kidney dysfunction, heart failure, arterial embolism, and glaucoma. TEAEs leading to death occurred in 17 patients (10.6%) receiving ivone...
The 9 TEAEs leading to ivonescimab discontinuation included elevated alanine aminotransferase, elevated serum creatinine, musculoskeletal pain, hypothyroidism, rash, kidney dysfunction, heart failure, arterial embolism, and glaucoma. TEAEs leading to death occurred in 17 patients (10.6%) receiving ivones...
The 9 TEAEs leading to ivonescimab discontinuation included elevated alanine aminotransferase, elevated serum creatinine, musculoskeletal pain, hypothyroidism, rash, kidney dysfunction, heart failure, arterial embolism, and glaucoma. TEAEs leading to death occurred in 17 patients (10.6%) receiving ivones...
The 9 TEAEs leading to ivonescimab discontinuation included elevated alanine aminotransferase, elevated serum creatinine, musculoskeletal pain, hypothyroidism, rash, kidney dysfunction, heart failure, arterial embolism, and glaucoma. TEAEs leading to death occurred in 17 patients (10.6%) receiving ivonesci...